KNSA - Kiniksa Pharmaceuticals International, plc
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$86.40
DETAILS
HIGH:
$99.00
LOW:
$71.00
MEDIAN:
$90.00
CONSENSUS:
$86.40
UPSIDE:
0.37%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Wood | 659,493 | $42.2M | 0.0% | +18,535 | INCREASED |
| Cooperman | 569,756 | $36.4M | 0.0% | -389,501 | DECREASED |
| Greenblatt | 4,799 | $306,896 | 0.0% | -2,775 | DECREASED |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-09-01 | Megna Michael R | officer: CHIEF ACCOUNTING OFFICER | M-Exempt | 3,932 | -- | -- |
| 2026-09-01 | Megna Michael R | officer: CHIEF ACCOUNTING OFFICER | M-Exempt | 2,362 | -- | -- |
| 2026-09-01 | Ragosa Mark | officer: CHIEF FINANCIAL OFFICER | F-InKind | 4,404 | $79.28 | $349K |
| 2026-09-01 | Ragosa Mark | officer: CHIEF FINANCIAL OFFICER | A-Award | 31,150 | $79.28 | $2.5M |
| 2026-09-01 | Patel Sanj K | director, officer: CHAIRMAN & CEO | F-InKind | 15,144 | $79.28 | $1.2M |
| 2026-09-01 | Patel Sanj K | director, officer: CHAIRMAN & CEO | A-Award | 30,050 | -- | -- |
| 2026-09-01 | Patel Sanj K | director, officer: CHAIRMAN & CEO | M-Exempt | 6,481 | -- | -- |
| 2026-09-01 | Moat Ross | officer: CHIEF OPERATING OFFICER | F-InKind | 4,007 | $79.28 | $318K |
| 2026-09-01 | Moat Ross | officer: CHIEF OPERATING OFFICER | A-Award | 9,250 | -- | -- |
| 2026-09-01 | Moat Ross | officer: CHIEF OPERATING OFFICER | M-Exempt | 1,611 | -- | -- |
| 2026-09-01 | Moat Ross | officer: CHIEF OPERATING OFFICER | M-Exempt | 2,477 | -- | -- |
| 2026-09-01 | Ragosa Mark | officer: CHIEF FINANCIAL OFFICER | M-Exempt | 1,591 | -- | -- |
| 2026-09-01 | Moat Ross | officer: CHIEF OPERATING OFFICER | A-Award | 36,950 | $79.28 | $2.9M |
| 2026-09-01 | Paolini John F. | officer: CHIEF MEDICAL OFFICER | F-InKind | 4,029 | $79.28 | $319K |
| 2026-09-03 | Megna Michael R | officer: CHIEF ACCOUNTING OFFICER | SELL | 4,600 | $80.30 | $369K |
| 2026-09-01 | Ragosa Mark | officer: CHIEF FINANCIAL OFFICER | M-Exempt | 3,069 | -- | -- |
| 2026-09-01 | Patel Sanj K | director, officer: CHAIRMAN & CEO | A-Award | 120,150 | $79.28 | $9.5M |
| 2026-09-01 | Ragosa Mark | officer: CHIEF FINANCIAL OFFICER | A-Award | 7,800 | -- | -- |
| 2026-09-01 | Ragosa Mark | officer: CHIEF FINANCIAL OFFICER | M-Exempt | 1,750 | -- | -- |
| 2026-09-01 | Paolini John F. | officer: CHIEF MEDICAL OFFICER | M-Exempt | 1,750 | -- | -- |
| 2026-09-01 | Paolini John F. | officer: CHIEF MEDICAL OFFICER | M-Exempt | 1,624 | -- | -- |
| 2026-09-01 | Megna Michael R | officer: CHIEF ACCOUNTING OFFICER | F-InKind | 5,531 | $79.28 | $438K |
| 2026-09-01 | Paolini John F. | officer: CHIEF MEDICAL OFFICER | M-Exempt | 2,497 | -- | -- |
| 2026-09-01 | Paolini John F. | officer: CHIEF MEDICAL OFFICER | A-Award | 26,750 | $79.28 | $2.1M |
| 2026-09-01 | Paolini John F. | officer: CHIEF MEDICAL OFFICER | M-Exempt | 2,457 | -- | -- |